An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Cited by (690)

Items 101–200 of 690

1. Antibody therapies for the prevention and treatment of viral infections
   Georgina To’a Salazar, Ningyan Zhang, Tong‐Ming Fu, Zhiqiang An · 2017 · npj Vaccines
2. Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer
   Christian Manegold, Donald S. Gravenor, Donald Woytowitz, Jörg Michael Mezger, Vera Hirsh, Gary R. Albert, Mohammed Al-Adhami, David Readett, Arthur Μ. Krieg, Cynthia Gail Leichman · 2008 · Journal of Clinical Oncology
3. Pathogenesis of severe acute respiratory syndrome
   YL Lau, Malik J. S. Peiris · 2005 · Current Opinion in Immunology
4. A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens
   Joshua Tan, Kathrin Pieper, Luca Piccoli, Abdirahman I. Abdi, Mathilde Foglierini, Roger Geiger, Claire Maria Tully, David Jarrossay, Francis Maina Ndungu, Juliana Wambua et al. · 2015 · Nature
5. Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer
   Anna Kabanova, Jessica Marcandalli, Tongqing Zhou, Siro Bianchi, Ulrich Baxa, Yaroslav Tsybovsky, Daniele Lilleri, Chiara Silacci-Fregni, Mathilde Foglierini, Blanca Maria Fernandez-Rodriguez et al. · 2016 · Nature Microbiology
6. Isolation of human monoclonal antibodies from peripheral blood B cells
   Jinghe Huang, Nicole A. Doria‐Rose, Nancy S. Longo, Leo Laub, Chien-Li Lin, Ellen Turk, Byong Ha Kang, Stephen A. Migueles, Robert T. Bailer, John R. Mascola et al. · 2013 · Nature Protocols
7. BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation
   Julia Eckl‐Dorna, Facundo D. Batista · 2009 · Blood
8. Toll-like receptors and innate immunity in B-cell activation and antibody responses
   Antonio Lanzavecchia, Federica Sallusto · 2007 · Current Opinion in Immunology
9. Understanding and making use of human memory B cells
   Antonio Lanzavecchia, Nadia L. Bernasconi, Elisabetta Traggiai, Claudia R. Ruprecht, Davide Corti, Federica Sallusto · 2006 · Immunological Reviews
10. T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020
    Vibha Jawa, Frances E. Terry, Jochem Gokemeijer, Shibani Mitra‐Kaushik, Brian Roberts, Sophie Tourdot, Anne Searls De Groot · 2020 · Frontiers in Immunology
11. Emerging Respiratory Viruses: Challenges and Vaccine Strategies
    Laura Gillim-Ross, Kanta Subbarao · 2006 · Clinical Microbiology Reviews
12. Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus
    Edward N. van den Brink, Jan ter Meulen, Freek Cox, Mandy A. C. Jongeneelen, Alexandra Thijsse, Mark Throsby, Wilfred E. Marissen, Pauline M.L. Rood, Alexander B. H. Bakker, Hans R. Gelderblom et al. · 2005 · Journal of Virology
13. Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
    Nigel James Temperton, Paul K.S. Chan, Graham Simmons, Maria Cristina Fleischmann Alves Zambon, Richard S. Tedder, Yasuhiro Takeuchi, Robin A. Weiss · 2005 · Emerging infectious diseases
14. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
    Ali Ahmed Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Ruchi Tiwari, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, Mamta Pathak, Yashpal Singh Malik, Kuldeep Dhama, Karam Pal Singh et al. · 2020 · Annals of Clinical Microbiology and Antimicrobials
15. Understanding the T cell immune response in SARS coronavirus infection
    Hsueh‐Ling Janice Oh, Samuel Ken‐En Gan, Antonio Bertoletti, Yee‐Joo Tan · 2012 · Emerging Microbes & Infections
16. B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
    Sonja Pötzsch, Nadja Spindler, Anna-Katharina Wiegers, Tanja Fisch, Pia Rücker, Heinrich Sticht, Nina Grieb, Tina Baroti, Florian J. Weisel, Thomas Stamminger et al. · 2011 · PLoS Pathogens
17. B Cells from Patients with Graves’ Disease Aberrantly Express the IGF-1 Receptor: Implications for Disease Pathogenesis
    Raymond S. Douglas, Vibharavi Naik, Catherine J. Hwang, Nikoo F. Afifiyan, Andrew George Gianoukakis, Daniel Sand, Shweta Kamat, Terry J. Smith · 2008 · The Journal of Immunology
18. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies
    Xiaocong Yu, Patricia A. McGraw, Frances S. House, James E. Crowe · 2008 · Journal of Immunological Methods
19. Tools to therapeutically harness the human antibody response
    Patrick C. Wilson, Sarah F. Andrews · 2012 · Nature reviews. Immunology
20. Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation
    Harini Narayanan, Fabian Dingfelder, Alessandro Butté, Nikolai Lorenzen, Michael Sokolov, Paolo Arosio · 2021 · Trends in Pharmacological Sciences
21. Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies
    Fei Song, Robert Fux, Lisette B. Provacia, Asisa Volz, Markus Eickmann, Stephan Becker, Albert D. M. E. Osterhaus, Bart L. Haagmans, Gerd Sutter · 2013 · Journal of Virology
22. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
    Subodh Kumar Samrat, Anil Mathew Tharappel, Zhong Li, Hongmin Li · 2020 · Virus Research
23. Animal models and vaccines for SARS-CoV infection
    Anjeanette Roberts, Elaine W. Lamirande, Leatrice Vogel, Jadon P. Jackson, Christopher D. Paddock, Jeannette Guarner, Sherif R. Zaki, Timothy Patrick Sheahan, Ralph Steven Baric, Kanta Subbarao · 2007 · Virus Research
24. Immune response in COVID-19: what is next?
    Qing Li, Ying Wang, Qiang Sun, Jasmin Knopf, Martin Herrmann i, Liangyu Lin, Jingting Jiang, Changshun Shao, Peishan Li, Xiaozhou He et al. · 2022 · Cell Death and Differentiation
25. D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity
    Jie Hu, Changlong He, Qingzhu Gao, Guiji Zhang, Xiaoxia Cao, Quanxin Long, Haijun Deng, Luyi Huang, Juan Chen, Kai Wang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
26. Third generation antibody discovery methods: in silico rational design
    Pietro Sormanni, Francesco A. Aprile, Michele Vendruscolo · 2018 · Chemical Society Reviews
27. Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus Challenge
    Rockx, Barry, Corti, Davide, Donaldson, Eric, Sheahan, Timothy, Stadler, Konrad, Lanzavecchia, Antonio, Baric, Ralph · 2008 · Journal of Virology
28. Development of Anti-Infectives Using Phage Display: Biological Agents against Bacteria, Viruses, and Parasites
    Johnny X. Huang, Sharon L. Bishop‐Hurley, Matthew A. Cooper · 2012 · Antimicrobial Agents and Chemotherapy
29. Isolation of Human Antibody Repertoires with Preservation of the Natural Heavy and Light Chain Pairing
    Per‐Johan Meijer, Peter Sejer Andersen, Margit Haahr Hansen, Lucilla Steinaa, Allan D. Jensen, Johan Lantto, Martin B. Oleksiewicz, Kaja Tengbjerg, Tine Rugh Poulsen, Vincent W. Coljee et al. · 2006 · Journal of Molecular Biology
30. Ex vivo characterization and isolation of rare memory B cells with antigen tetramers
    Bettina Franz, Kenneth F. May, Glenn Dranoff, Kai W. Wucherpfennig · 2011 · Blood
31. Mechanisms of Zoonotic Severe Acute Respiratory Syndrome Coronavirus Host Range Expansion in Human Airway Epithelium
    Timothy Patrick Sheahan, Barry Rockx, Eric Donaldson, Amy María Sims, Raymond John Pickles, Davide Corti, Ralph Steven Baric · 2007 · Journal of Virology
32. Hybridoma Technology for the Generation of Monoclonal Antibodies
    Chonghui Zhang · 2012 · Methods in molecular biology
33. Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies
    Anna Kabanova, Laurent H. Perez, Daniele Lilleri, Jessica Marcandalli, Gloria Agatic, Simone Becattini, Silvia Preite, Dario Fuschillo, Elena Percivalle, Federica Sallusto et al. · 2014 · Proceedings of the National Academy of Sciences
34. Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease
    Luis Enjuanes, Marta L. DeDiego, Enrique Alarcón Álvarez, Damon Deming, Tim Sheahan, Ralph Steven Baric · 2007 · Virus Research
35. Dissecting the human immunologic memory for pathogens
    Christina E. Zielinski, Davide Corti, Federico Mele, Dora Pinto, Antonio Lanzavecchia, Federica Sallusto · 2011 · Immunological Reviews
36. Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
    Savannah E. Butler, Andrew R. Crowley, Harini Natarajan, Shiwei Xu, Joshua A. Weiner, Carly A. Bobak, Daniel E. Mattox, Jiwon Lee, Wendy Wieland‐Alter, Ruth I. Connor et al. · 2021 · Frontiers in Immunology
37. A human SARS-CoV neutralizing antibody against epitope on S2 protein
    Duan, Jinzhu, Yan, Xiyun, Guo, Xueming, Cao, Wuchun, Han, Wei, Qi, Cai, Feng, Jing, Yang, Dongling, Gao, Guangxia, Jin, Gang · 2005 · Biochemical and Biophysical Research Communications
38. A Live Attenuated Severe Acute Respiratory Syndrome Coronavirus Is Immunogenic and Efficacious in Golden Syrian Hamsters
    Elaine W. Lamirande, Marta L. DeDiego, Anjeanette Roberts, Jadon P. Jackson, Enrique Alarcón Álvarez, Tim Sheahan, Wun‐Ju Shieh, Sherif R. Zaki, Ralph Steven Baric, Luis Enjuanes et al. · 2008 · Journal of Virology
39. Fungal vaccines: real progress from real challenges
    Antonio Cassone · 2008 · The Lancet Infectious Diseases
40. Pneumonitis and Multi-Organ System Disease in Common Marmosets (Callithrix jacchus) Infected with the Severe Acute Respiratory Syndrome-Associated Coronavirus
    Thomas C. Greenough, Angela Carville, James A. Coderre, Mohan Somasundaran, John L. Sullivan, Katherine Luzuriaga, Keith G. Mansfield · 2005 · American Journal Of Pathology
41. Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
    Nicky Dunn, Alexander Juto, Malin Lundkvist Ryner, Ali Manouchehrinia, Luca Piccoli, Katharina Fink, Fredrik Piehl, Anna Fogdell‐Hahn · 2017 · Multiple Sclerosis Journal
42. From Pasteur to genomics: progress and challenges in infectious diseases
    Rino Rappuoli · 2004 · Nature Medicine
43. Human pregnancy‐associated malaria‐specific B cells target polymorphic, conformational epitopes in VAR2CSA: This article became available OnlineOpen after it was first published online on 14 December 2006 [14 February 2007].
    Barfod, Lea, Bernasconi, Nadia L., Dahlbäck, Madeleine, Jarrossay, David, Andersen, Pernille Haste, Salanti, Ali, Ofori, Michael F., Turner, Louise, Resende, Mafalda, Nielsen, Morten A. et al. · 2007 · Molecular Microbiology
44. Barcode‐Enabled Sequencing of Plasmablast Antibody Repertoires in Rheumatoid Arthritis
    Yann‐Chong Tan, Sarah Kongpachith, Lisa K. Blum, Chia‐Hsin Ju, Lauren J. Lahey, Daniel Lu, Xiaoyong Cai, Catriona A. Wagner, Tamsin M. Lindström, Jeremy B. Sokolove et al. · 2014 · Arthritis & Rheumatology
45. Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology
    Jody D. Berry, Kevin Anthony Hay, James M. Rini, Meng Yu, Lin‐Fa Wang, Francis Allan Plummer, Cindi R. Corbett, Anton P. Andonov · 2010 · mAbs
46. Toll‐like receptors: key activators of leucocytes and regulator of haematopoiesis
    Anne F. McGettrick, Luke A.J. O'Neill · 2007 · British Journal of Haematology
47. Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis
    Luca Piccoli, Ilaria Campo, Chiara Silacci Fregni, Blanca M. Fernandez Rodriguez, Andrea Minola, Federica Sallusto, Maurizio Luisetti, Davide Corti, Antonio Lanzavecchia · 2015 · Nature Communications
48. Techniques to Study Antigen-Specific B Cell Responses
    Jim B. Boonyaratanakornkit, Justin J. Taylor · 2019 · Frontiers in Immunology
49. Is there an ideal animal model for SARS?
    Kanta Subbarao, Anjeanette Roberts · 2006 · Trends in Microbiology
50. Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
    De Benedictis, Paola, Minola, Andrea, Rota Nodari, Elena, Aiello, Roberta, Zecchin, Barbara, Salomoni, Angela, Foglierini, Mathilde, Agatic, Gloria, Vanzetta, Fabrizia, Lavenir, Rachel et al. · 2016 · EMBO Molecular Medicine
51. Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters
    Anjeanette Roberts, William D. Thomas, Jeannette Guarner, Elaine W. Lamirande, Gregory J. Babcock, Thomas C. Greenough, Leatrice Vogel, Norman Hayes, John L. Sullivan, Sherif R. Zaki et al. · 2006 · The Journal of Infectious Diseases
52. Public antibodies to malaria antigens generated by two LAIR1 insertion modalities
    Kathrin Pieper, Joshua Tan, Luca Piccoli, Mathilde Foglierini, Sonia Barbieri, Yiwei Chen, Chiara Silacci-Fregni, Tobias Wolf, David Jarrossay, Marica Anderle et al. · 2017 · Nature
53. Vaccinology at the beginning of the 21st century
    Andreas Wack, Rino Rappuoli · 2005 · Current Opinion in Immunology
54. Antiinfective Applications of Toll-like Receptor 9 Agonists
    ARTHUR M. KRIEG · 2007 · Proceedings of the American Thoracic Society
55. Immuno-engineered organoids for regulating the kinetics of B-cell development and antibody production
    Alberto Purwada, Ankur Singh · 2016 · Nature Protocols
56. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines
    Yuxian He, Qingyu Zhu, Shuwen Liu, Yusen Zhou, Yang Baoan, Jiaming Li, Shibo Jiang · 2005 · Virology
57. Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1
    Miroslaw K. Górny, Xiaohong Wang, Constance A. U. Williams, Barbara Volsky, Kathy Revesz, Bradley Witover, Sherri T. Burda, Mateusz M. Urbanski, Phillipe N. Nyambi, Chavdar P. Krachmarov et al. · 2008 · Molecular Immunology
58. The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
    Longping V. Tse, Rita M. Meganck, Rachel L. Graham, Ralph Steven Baric · 2020 · Frontiers in Microbiology
59. Global trends in coronavirus research at the time of Covid-19: A general bibliometric approach and content analysis using SciMAT
    Enrique Herrera‐Viedma, José-Ricardo López-Robles, Javier Guallar, Manuel J. Cobo · 2020 · El Profesional de la Informacion
60. Enhanced humoral and HLA‐A2‐restricted dengue virus‐specific T‐cell responses in humanized BLT NSG mice
    Smita Jaiswal, Pamela Pazoles, Marcia Woda, Leonard D. Shultz, Dale L. Greiner, Michael A. Brehm, Anuja Mathew · 2012 · Immunology
61. The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries
    R. Arjen Kramer, Wilfred E. Marissen, Jaap Goudsmit, Therèse Visser, Marieke Clijsters-van der Horst, Arjen Q. Bakker, Maureen de Jong, Mandy A. C. Jongeneelen, Sandra Thijsse, Harold H.J. Backus et al. · 2005 · European Journal of Immunology
62. Common Variants in CDKN2B-AS1 Associated with Optic-Nerve Vulnerability of Glaucoma Identified by Genome-Wide Association Studies in Japanese
    Masakazu Nakano, Yoko Ikeda, Yuichi Tokuda, Masahiro Fuwa, Natsue Omi, Morio Ueno, Kojiro Imai, Hiroko Adachi, Masaaki Kageyama, Kazuhiko Mori et al. · 2012 · PLoS ONE
63. VP24 of Marburg Virus Influences Formation of Infectious Particles
    Sandra Bamberg, Larissa Kolesnikova, Peggy Möller, Hans‐Dieter Klenk, Stephan Becker · 2005 · Journal of Virology
64. Immunosenescence and Influenza Vaccine Efficacy
    Suryaprakash R. Sambhara, Janet E. McElhaney · 2009 · Current topics in microbiology and immunology
65. Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
    Joyce S Hui‐Yuen, Shane C. McAllister, Siva Rama Krishna Koganti, Erik R. Hill, Sumita Bhaduri‐McIntosh · 2011 · Journal of Visualized Experiments
66. Treatment and vaccines for severe acute respiratory syndrome
    David Alexander Groneberg, Susan Marie Poutanen, Donald E. Low, Hartmut M Lode, Tobias Welte, P. Zabel · 2005 · The Lancet Infectious Diseases
67. Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients
    Ellen J. Collarini, F. Eun-Hyung Lee, Orit Foord, Minha Park, Gizette V. Sperinde, Hai Wu, William D. Harriman, Stephen F. Carroll, Stote L. Ellsworth, Larry J. Anderson et al. · 2009 · The Journal of Immunology
68. Influence of FcγRIIA and MBL polymorphisms on severe acute respiratory syndrome
    F. F. Yuan, Julian A. Tanner, Paul K.S. Chan, Sandra Biffin, Wayne B. Dyer, Andrew F. Geczy, Julian Wei-Tze Tang, David S.C. Hui, Joseph J.�Y. Sung, John S. Sullivan · 2005 · Tissue Antigens
69. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
    Johannes F. Scheid, Christopher O. Barnes, Basak Eraslan, Andrew Hudak, Jennifer R. Keeffe, Lisa A. Cosimi, Eric Brown, Frauke Muecksch, Yiska Weisblum, Shuting Zhang et al. · 2021 · Cell
70. The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
    Conrad En Zuo Chan, Shirley G. K. Seah, De Hoe Chye, Shane Massey, Maricela Torres, Angeline Pei Chiew Lim, Steven K. K. Wong, Jacklyn J. Y. Neo, Pui San Wong, Jie Hui Lim et al. · 2021 · PLoS ONE
71. Human B cell memory
    Antonio Lanzavecchia, Federica Sallusto · 2009 · Current Opinion in Immunology
72. A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection
    Lisa F. P. Ng, Martin Lloyd Hibberd, Eng Eong Ooi, Kin Fai Tang, Soek-Ying Neo, J. S. Tan, K. R. K. Murthy, Vinsensius Berlian Vega, Jer-Ming Chia, Edison T. Liu et al. · 2004 · BMC Infectious Diseases
73. Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies
    Amy E. Gilbert, Panagiotis Karagiannis, Tihomir S. Dodev, Alexander Koers, Katie E. Lacy, Debra Hannah Josephs, Pooja Takhar, Jenny L. C. Geh, Ciaran Healy, Mark Harries et al. · 2011 · PLoS ONE
74. Single B cell antibody technologies
    Thomas Tiller · 2011 · New Biotechnology
75. Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
    Scott Alan Smith, James E. Crowe · 2015 · Microbiology Spectrum
76. Rapid Generation of Rotavirus-Specific Human Monoclonal Antibodies from Small-Intestinal Mucosa
    Roberto Di Niro, Luka Mesin, Melinda Ráki, Nai‐Ying Zheng, Fridtjof Lund‐Johansen, Knut E. A. Lundin, Annie Charpilienne, Didier Poncet, Patrick C. Wilson, Ludvig Magne Sollid · 2010 · The Journal of Immunology
77. Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential
    Melissa M. Coughlin, Bellur S. Prabhakar · 2011 · Reviews in Medical Virology
78. The role of phage display in therapeutic antibody discovery
    Conrad En Zuo Chan, Angeline Pei Chiew Lim, Paul A. MacAry, Brendon John Hanson · 2014 · International Immunology
79. Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions
    David C. Montefiori, Quentin James Sattentau, Jorge Flores, José Esparza, John R. Mascola, on behalf of a Working Group convened by the Global HIV Vaccine Enterprise · 2007 · PLoS Medicine
80. COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
    John P. Moore, Per Johan Klasse · 2020 · Journal of Virology
81. Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies
    Rohit Kumar Singh, Pankaj Chandley, Soma Rohatgi · 2023 · ImmunoHorizons
82. Microfluidic single-cell technology in immunology and antibody screening
    Samantha Seah, Hongxing Hu, Christoph A. Merten · 2017 · Molecular Aspects of Medicine
83. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection
    Synat Keam, Dewi Megawati, Shailesh Kumar Patel, Ruchi Tiwari, Kuldeep Dhama, Harapan Harapan · 2020 · Reviews in Medical Virology
84. Human Antibody Neutralizes Severe Fever with Thrombocytopenia Syndrome Virus, an Emerging Hemorrhagic Fever Virus
    Xiling Guo, Li Zhang, Wenshuai Zhang, Ying Chi, Xiaoyan Zeng, Xian Li, Xian Qi, Jin Feng Qiu, Xiao Zhang, Mingming Huang et al. · 2013 · Clinical and Vaccine Immunology
85. Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus
    Barry Rockx, Eric Donaldson, Matthew B. Frieman, Timothy Patrick Sheahan, Davide Corti, Antonio Lanzavecchia, Ralph Steven Baric · 2010 · The Journal of Infectious Diseases
86. Broadening of Neutralization Activity to Directly Block a Dominant Antibody-Driven SARS-Coronavirus Evolution Pathway
    Jianhua Sui, Daniel R. Aird, Azaibi Tamin, Akikazu Murakami, Meiying Yan, Anuradha Yammanuru, Huaiqi Jing, Biao Kan, Xin Liu, Quan Karen Zhu et al. · 2008 · PLoS Pathogens
87. Structural and functional analysis of a potent sarbecovirus neutralizing antibody
    Dora Pinto, Young‐Jun Park, Martina Beltramello, Alexandra C. Walls, M. Alejandra Tortorici, Siro Bianchi, Stefano Jaconi, Katja Culap, Fabrizia Zatta, Anna De Marco et al. · 2020 · Worldwide Protein Data Bank
88. Development and optimization of a process for automated recovery of single cells identified by microengraving
    Jae-Hyeok Choi, Adebola O. Ogunniyi, Mindy Du, Minna Du, Marcel Kretschmann, Jens Eberhardt, John Christopher Love · 2010 · Biotechnology Progress
89. Assessing antibody and nanobody nativeness for hit selection and humanization with AbNatiV
    Aubin Ramon, Montader Ali, Misha Atkinson, Alessio Saturnino, Kieran Didi, Cristina Visentin, Stéfano Ricagno, Xing Xu, Matthew Greenig, Pietro Sormanni · 2024 · Nature Machine Intelligence
90. Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2
    Deepak Singh Chauhan, Rajendra Prasad, Rohit Srivastava, Meena Jaggi, Subhash C. Chauhan, Murali Mohan Yallapu · 2020 · Bioconjugate Chemistry
91. Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
    Arif Hussain, Anwarul Hasan, Mohammad Mahdi Nejadi Babadaei, Samir Haj Bloukh, Muhammad E. H. Chowdhury, Majid Sharifi, Setareh Haghighat, Mojtaba Falahati · 2020 · Biomedicine & Pharmacotherapy
92. Immunotherapeutic approaches to curtail COVID-19
    Hajar Owji, Manica Negahdaripour, Nasim Hajighahramani · 2020 · International Immunopharmacology
93. Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
    Nicholas K. Hurlburt, Leah J. Homad, Irika R. Sinha, Madeleine F. Jennewein, Anna J. MacCamy, Yu-Hsin Wan, Jim B. Boonyaratanakornkit, Anton M. Sholukh, Abigail M. Jackson, Pan-Pan Zhou et al. · 2022 · Communications Biology
94. Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19
    Erik Hans Vogelzang, Floris C. Loeff, Ninotska I. L. Derksen, Simone Kruithof, Pleuni Ooijevaar‐de Heer, Gerard J. van Mierlo, Federica Linty, Juk Yee Mok, Wim J.E. van Esch, Sanne de Bruin et al. · 2020 · The Journal of Immunology
95. Clonal structure, stability and dynamics of human memory B cells and circulating plasmablasts
    Ganesh E. Phad, Dora Pinto, Mathilde Foglierini, Murodzhon Akhmedov, Riccardo Lorenzo Rossi, Emilia Malvicini, Antonino Cassotta, Chiara Silacci Fregni, Ludovica Bruno, Federica Sallusto et al. · 2022 · Nature Immunology
96. Human monoclonal antibodies by immortalization of memory B cells
    Antonio Lanzavecchia, Davide Corti, Federica Sallusto · 2007 · Current Opinion in Biotechnology
97. Generation of Human Antigen-Specific Monoclonal IgM Antibodies Using Vaccinated “Human Immune System” Mice
    Pablo Daniel Becker, Nicolas Legrand, Caroline M. M. van Geelen, Miriam Nörder, Nicholas D. Huntington, Annick Lim, Etsuko Yasuda, Sean A. Diehl, Ferenc A. Scheeren, Michael Ott et al. · 2010 · PLoS ONE
98. T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a–specific, HLA-DRB3*0101–restricted CD4+ T cells
    Maria Therese Ahlén, Anne Husebekk, Mette Kjær Killie, Bjørn R. Skogen, Tor Brynjar Stuge · 2009 · Blood
99. Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection
    Yongjun Guan, Mohammad M. Sajadi, Roberta Kamin‐Lewis, TIMOTHY R. FOUTS, Anthony Dimitrov, Zhixin Zhang, Robert R. Redfield, Anthony L. DeVico, Robert C. Gallo, George K. Lewis · 2009 · Proceedings of the National Academy of Sciences
100. Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies
     Mengjie Hu, Marie A. Bogoyevitch, David A. Jans · 2020 · Physiological Reviews